Department of Dentistry-Regenerative Biomaterials, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Bioengineering (MS142), Rice University, Houston, Texas, USA.
Tissue Eng Part A. 2023 Mar;29(5-6):161-171. doi: 10.1089/ten.TEA.2022.0177. Epub 2023 Jan 27.
The aim of this preclinical study was to test the applicability of calcium phosphate cement (CPC)-poly(lactic-co-glycolic acid) (PLGA)-carboxymethylcellulose (CMC) as a bone substitute material for guided bone regeneration (GBR) procedures in a clinically relevant mandibular defect model in minipigs. In the study, a predicate device (i.e., BioOss) was included for comparison. Critical-sized circular mandibular bone defects were created and filled with either CPC-PLGA-CMC without coverage with a GBR membrane or BioOss covered with a GBR membrane and left to heal for 4 and 12 weeks to obtain temporal insight in material degradation and bone formation. Bone formation increased significantly for both CPC-PLGA-CMC and BioOss with increasing implantation time. Further, no significant differences were found for bone formation at either 4 or 12 weeks between CPC-PLGA-CMC and BioOss. Finally, bone substitute material degradation increased significantly for both CPC-PLGA-CMC and BioOss from 4 to 12 weeks of implantation, showing the highest degradation for CPC-PLGA-CMC (∼85%) compared to BioOss (∼12%). In conclusion, this minipig study showed that CPC-PLGA-CMC can be used as a bone-grafting material and stimulates bone regeneration to a comparable extent as with BioOss particles. Importantly, CPC-PLGA-CMC degrades faster compared to BioOss, is easier to apply into a bone defect, and does not need the use of an additional GBR membrane. Consequently, the data support the further investigation of CPC-PLGA-CMC in human clinical trials. Impact statement Guided bone regeneration (GBR) is a frequently used dental surgical technique to regenerate the alveolar ridge to allow stable implant installation. However, stabilization of the GBR membrane and avoidance of bone graft movement remain a challenge. Consequently, there is need for the development of alternative materials to be used in GBR procedures that are easier to apply and induce predictable bone regeneration. In this minipig study, we focused on the applicability of calcium phosphate cement-poly(lactic-co-glycolic acid)-carboxymethylcellulose as an alternative bone substitute material for GBR procedures without the need of an additional GBR membrane.
本临床前研究旨在测试磷酸钙水泥(CPC)-聚(乳酸-共-乙醇酸)(PLGA)-羧甲基纤维素(CMC)作为引导骨再生(GBR)程序中骨替代材料的适用性,该材料在小型猪的临床相关下颌骨缺损模型中进行了研究。在该研究中,包含了一种对照设备(即 BioOss)进行比较。创建了临界尺寸的圆形下颌骨缺损,并分别用 CPC-PLGA-CMC 填充,无需 GBR 膜覆盖,或用 GBR 膜覆盖的 BioOss 并在 4 和 12 周时进行愈合,以获得材料降解和骨形成的时间性见解。随着植入时间的增加,CPC-PLGA-CMC 和 BioOss 的骨形成均显著增加。此外,在 4 或 12 周时,CPC-PLGA-CMC 和 BioOss 之间的骨形成均无显著差异。最后,从植入后的 4 周到 12 周,CPC-PLGA-CMC 和 BioOss 的骨替代材料降解均显著增加,与 BioOss(约 12%)相比,CPC-PLGA-CMC 的降解率最高(约 85%)。总之,本小型猪研究表明,CPC-PLGA-CMC 可用作骨移植材料,刺激骨再生的程度与 BioOss 颗粒相当。重要的是,与 BioOss 相比,CPC-PLGA-CMC 的降解速度更快,更易于应用于骨缺损,并且不需要使用额外的 GBR 膜。因此,数据支持 CPC-PLGA-CMC 在人类临床试验中的进一步研究。
引导骨再生(GBR)是一种常用的牙科手术技术,用于再生牙槽嵴,以允许稳定的植入物安装。然而,GBR 膜的稳定和避免骨移植物的移动仍然是一个挑战。因此,需要开发替代材料用于 GBR 程序,这些材料更容易应用并诱导可预测的骨再生。在本小型猪研究中,我们专注于磷酸钙水泥-聚(乳酸-共-乙醇酸)-羧甲基纤维素作为 GBR 程序中替代骨替代材料的适用性,而无需额外的 GBR 膜。